{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:51:59Z","timestamp":1792083119001,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI164100"],"award-info":[{"award-number":["R21AI164100"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","award":["58293-I"],"award-info":[{"award-number":["58293-I"]}],"id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.anai.2024.11.025","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T17:18:30Z","timestamp":1733246310000},"page":"587-593.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A health economic analysis of noninjectable epinephrine compared with intramuscular epinephrine"],"prefix":"10.1016","volume":"134","author":[{"given":"Marcus S.","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.K.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Anagnostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anai.2024.11.025_bib0001","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.anai.2023.05.033","article-title":"Innovations in the treatment of anaphylaxis: a review of recent data","volume":"131","author":"Lieberman","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2024.11.025_bib0002","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.anai.2023.12.003","article-title":"Inhaled epinephrine for anaphylaxis: time for another look?","volume":"132","author":"Shaker","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2024.11.025_bib0003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.anai.2023.10.024","article-title":"Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma","volume":"132","author":"Ho","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2024.11.025_bib0004","unstructured":"Amazon.com. Primatene Mist $30.98. Accessed July 28, 2024. Available at: https:\/\/www.amazon.com"},{"issue":"11","key":"10.1016\/j.anai.2024.11.025_bib0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamapediatrics.2013.2376","article-title":"The economic impact of childhood food allergy in the United States","volume":"167","author":"Gupta","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.anai.2024.11.025_bib0006","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.anai.2020.01.004","article-title":"Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy","volume":"124","author":"Shaker","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2024.11.025_bib0007","unstructured":"GoodRx. Generic EpiPen. Accessed November 2, 2204. Available at:https:\/\/www.goodrx.com\/epipen?utm_campaign=115271701&utm_content=120588129794&utm_source=google&utm_medium=cpc&utm_term=kwd-930975690682&gclid=Cj0KCQjwm5e5BhCWARIsANwm06jOvPZ1NB4M31jCsKboH54nNXHogy5yPE5Mp59V43JQPWWvtIT0JM4aAlEkEALw_wcB&gclsrc=aw.ds"},{"key":"10.1016\/j.anai.2024.11.025_bib0008","article-title":"Estimating cost-effectiveness of confirmatory oral food challenges in the diagnosis of children with food allergy","volume":"6","author":"Alsaggaf","year":"2019","journal-title":"Glob Pediatr Health"},{"issue":"12","key":"10.1016\/j.anai.2024.11.025_bib0009","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.jaip.2022.08.011","article-title":"The impact of allergy specialty care on health care utilization among peanut allergy children in the United States","volume":"10","author":"Greenhawt","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2024.11.025_bib0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/cea.12211","article-title":"Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis","volume":"43","author":"Umasunthar","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2024.11.025_bib0011","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-045831","article-title":"Safely reducing hospitalizations for anaphylaxis in children through an evidence-based guideline","volume":"149","author":"Gaffney","year":"2022","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.anai.2024.11.025_bib0012","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaci.2022.04.008","article-title":"The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study","volume":"150","author":"Peters","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2024.11.025_bib0013","doi-asserted-by":"crossref","first-page":"e12064","DOI":"10.1002\/clt2.12064","article-title":"Incidence of anaphylaxis and accidental peanut exposure: a systematic review","volume":"11","author":"Muraro","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.anai.2024.11.025_bib0014","unstructured":"US Bureau of Labor Statistics. The economic daily. Consumer Price Index: 2023 in review. Accessed April 27, 2024. Available at: https:\/\/www.bls.gov\/opub\/ted\/2024\/consumer-price-index-2023-in-review.htm"},{"key":"10.1016\/j.anai.2024.11.025_bib0015","unstructured":"Oral immunotherapy and Viaskin\u00ae peanut for peanut allergy: effectiveness and value. Institute for Clinical and Economic Review. Accessed March 16, 2024. Available at: https:\/\/icer.org\/wp-content\/uploads\/2020\/10\/ICER_PeanutAllergy_Final_Report_071019.pdf"},{"issue":"5","key":"10.1016\/j.anai.2024.11.025_bib0016","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.anai.2016.02.016","article-title":"The economic effect and outcome of delaying oral food challenges","volume":"116","author":"Couch","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.11.025_bib0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2009.01.040","article-title":"Improving decision analyses: parent preferences (utility values) for pediatric health outcomes","volume":"155","author":"Carroll","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.anai.2024.11.025_bib0018","unstructured":"GoodRx. Neffy. Accessed November 2, 2024. Available at: https:\/\/www.goodrx.com\/neffy"},{"key":"10.1016\/j.anai.2024.11.025_bib0019","unstructured":"ARS Pharma. ARS Pharmaceuticals Receives FDA Approval of neffy\u00ae (Epinephrine Nasal Spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis. https:\/\/ir.ars-pharma.com\/news-releases\/news-release-details\/ars-pharmaceuticals-receives-fda-approval-neffyr-epinephrine. Accessed November 22, 2024."},{"issue":"9","key":"10.1016\/j.anai.2024.11.025_bib0020","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jaip.2024.06.023","article-title":"The cost-effectiveness of omalizumab for treatment of food allergy","volume":"12","author":"Shaker","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2024.11.025_bib0021","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.jaip.2024.06.042","article-title":"Hope and team medicine","volume":"12","author":"Shaker","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2024.11.025_bib0022","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.anai.2024.09.009","article-title":"Perceptions, realities, and alternatives in rescue epinephrine","volume":"133","author":"Greenhawt","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2024.11.025_bib0023","unstructured":"Goodreads. W. Edwards Deming quotes. Accessed August 3, 2024. Available at:https:\/\/www.goodreads.com\/quotes\/7224415-every-system-is-perfectly-designed-to-get-the-result-that"},{"issue":"5","key":"10.1016\/j.anai.2024.11.025_bib0024","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaip.2024.02.039","article-title":"Pharmacoequity and biologics in the allergy clinic: providing the right care, at the right time, every time, to everyone","volume":"12","author":"Conway","year":"2024","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624017150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624017150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:23:29Z","timestamp":1747149809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624017150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1081120624017150"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.11.025","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A health economic analysis of noninjectable epinephrine compared with intramuscular epinephrine","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}